Inj, fosaprepitant (teva)
Products billed under this code include Fosaprepitant.
Payment limit per 1 MG, by effective quarter, 2Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Fosaprepitant.
Payment limit per 1 MG, by effective quarter, 2Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Fosaprepitant | Actavis Pharma, Inc. | 00591-4385-79 | 150 | $5.40 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.036 | $0.00 | 1 MG | Inj, fosaprepitant (teva) | v1, posted September 17, 2026 |
| 3Q26 | $0.036 | $0.00 | 1 MG | Inj, fosaprepitant (teva) | v1, posted September 15, 2026 |
| 2Q26 | $0.036 | −$0.603 | 1 MG | Inj, fosaprepitant (teva) | v1, posted September 15, 2026 |
| 1Q26 | $0.639 | −$0.391 | 1 MG | Inj, fosaprepitant (teva) | v1, posted September 15, 2026 |
| 4Q25 | $1.03 | −$0.10 | 1 MG | Inj, fosaprepitant (teva) | v1, posted September 8, 2026 |
| 3Q25 | $1.13 | −$0.084 | 1 MG | Inj, fosaprepitant (teva) | v1, posted March 10, 2026 |
| 2Q25 | $1.214 | +$0.773 | 1 MG | Inj, fosaprepitant (teva) | v1, posted March 10, 2026 |
| 1Q25 | $0.441 | −$1.602 | 1 MG | Inj, fosaprepitant (teva) | v1, posted December 19, 2025 |
| 4Q24 | $2.043 | $0.00 | 1 MG | Inj, fosaprepitant (teva) | v1, posted June 11, 2025 |
| 3Q24 | $2.043 | $0.00 | 1 MG | Inj, fosaprepitant (teva) | v1, posted June 11, 2025 |
| 2Q24 | $2.043 | +$1.602 | 1 MG | Inj, fosaprepitant (teva) | v1, posted March 11, 2025 |
| 1Q24 | $0.441 | +$0.267 | 1 MG | Inj, fosaprepitant (teva) | v1, posted December 19, 2024 |
| 4Q23 | $0.174 | +$0.076 | 1 MG | Inj, fosaprepitant (teva) | v1, posted October 10, 2024 |
| 3Q23 | $0.098 | −$0.324 | 1 MG | Inj, fosaprepitant (teva) | v1, posted June 5, 2024 |
| 2Q23 | $0.422 | – | 1 MG | Inj, fosaprepitant (teva) | v1, posted February 23, 2024 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.